https://www.selleckchem.com/pr....oducts/guggulsterone
46 [0.27-0.76]; p=0.002, Log rank p less then 0.001) against an early recurrence. Regarding the long-term recurrence, pre-ECV heart failure was protective against an AF recurrence (hazard ratio, 0.63 [0.41-0.96], p=0.033) over 32 (9-66) months of follow-up. ECV energy (p less then 0.001) and early recurrence rate within 3 months (p=0.007, Log rank p=0.006) were significantly lower in post-ablation patients than in those with long-standing persistent AF. CONCLUSIONS The success rate of OPC-ECV was 88.6%, and the complication rate w